Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-related macular degeneration; OPC1, an oligodendrocyte progenitor cell therapy that is in Phase I/IIa multicenter clinical trial for the treatment of acute spinal cord injuries; and VAC2, an allogeneic cancer immunotherapy of antigen-presenting dendritic cells, which is in Phase I clinical trial to treat non-small cell lung cancer. It also offers Renevia, a facial aesthetics product. In addition, the company engages in the research and development of therapeutic products for retinal diseases, neurological diseases, and disorders and oncology. Lineage Cell Therapeutics, Inc. has a collaboration with Orbit Biomedical, Ltd. The company was formerly known as BioTime, Inc. and changed its name to Lineage Cell Therapeutics, Inc. in August 2019. Lineage Cell Therapeutics, Inc. was incorporated in 1990 and is headquartered in Carlsbad, California.
Over the last 12 months, insiders at Lineage Cell Therapeutics, Inc. have bought $7.12M and sold $0 worth of Lineage Cell Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Lineage Cell Therapeutics, Inc. have bought $2.42M and sold $1.35M worth of stock each year.
Highest buying activity among insiders over the last 12 months: BROADWOOD PARTNERS, L.P. () — $21M. BAILEY DON M (director) — $200,002. Culley Brian M (President and CEO) — $21,000.
The last purchase of 10,000 shares for transaction amount of $10,500 was made by Culley Brian M (President and CEO) on 2024‑05‑24.
2024-05-24 | Culley Brian M | President and CEO | 10,000 0.0054% | $1.05 | $10,500 | -9.76% | ||
2024-02-08 | BAILEY DON M | director | 96,155 0.0563% | $1.04 | $100,001 | +2.31% | ||
2024-02-06 | BROADWOOD PARTNERS, L.P. | 6.73M 3.9412% | $1.04 | $7M | -0.90% | |||
2023-12-29 | Jayasuriya Anula | director | 10,000 0.0057% | $1.09 | $10,900 | +1.85% | ||
2022-03-31 | Culley Brian M | President and CEO | 6,400 0.0037% | $1.53 | $9,792 | -11.04% | ||
2022-03-28 | Amin Dipti | 35,000 0.0227% | $1.63 | $57,050 | -7.43% | |||
2022-03-25 | Culley Brian M | President and CEO | 5,250 0.0029% | $1.38 | $7,245 | -7.43% | ||
2022-03-24 | Mulroy Michael H. | 7,000 0.004% | $1.40 | $9,800 | -4.86% | |||
2022-03-23 | BRADSHER NEAL C | 0 – | $0 | $0 | -0.72% | |||
2021-12-29 | Sale | Hogge Gary S. | SVP,Clinical & Medical Affairs | 37,695 0.0227% | $2.45 | $92,438 | -43.21% | |
2021-12-28 | Sale | Hogge Gary S. | SVP,Clinical & Medical Affairs | 501,588 0.298% | $2.45 | $1.23M | -43.70% | |
2021-06-29 | Sale | Russell Angus C. | director | 4,720 0.0029% | $2.97 | $14,018 | -29.69% | |
2021-06-29 | Sale | ANDREWS DEBORAH J | director | 19,142 0.0117% | $2.93 | $56,086 | -29.69% | |
2021-06-28 | Sale | Culley Brian M | President and CEO | 450,000 0.2743% | $2.87 | $1.29M | -28.72% | |
2021-03-30 | Sale | Hernandez Alexandra | Sr Director Finance/Controller | 6,000 0.0037% | $2.23 | $13,380 | +6.64% | |
2019-08-15 | BROADWOOD PARTNERS, L.P. | 13,146 0.0088% | $0.97 | $12,717 | -4.89% | |||
2019-08-14 | BROADWOOD PARTNERS, L.P. | 1,407 0.0009% | $0.98 | $1,379 | -4.35% | |||
2019-08-13 | BROADWOOD PARTNERS, L.P. | 10,000 0.0065% | $0.99 | $9,949 | -4.35% | |||
2019-08-13 | Culley Brian M | President and CEO | 10,000 0.0066% | $1.01 | $10,100 | -4.35% | ||
2019-08-13 | Roberts Brandi | CFO & SVP, Finance | 5,000 0.0033% | $1.01 | $5,050 | -4.35% |
BROADWOOD PARTNERS, L.P. | 41666255 22.1067% | $0.90 | 19 | 1 | +10.66% | |
BAILEY DON M | director | 158801 0.0843% | $0.90 | 1 | 0 | |
Culley Brian M | President and CEO | 154842 0.0519% | $0.90 | 4 | 1 | <0.0001% |
Jayasuriya Anula | director | 10000 0.0053% | $0.90 | 1 | 0 | |
BRADSHER NEAL C | 34265485 18.1801% | $0.90 | 4 | 0 | <0.0001% | |
KINGSLEY ALFRED D | See Remarks | 5781555 3.0675% | $0.90 | 13 | 8 | |
WEST MICHAEL D | Co-Chief Executive Officer | 882864 0.4684% | $0.90 | 3 | 1 | +1.12% |
SEGALL JUDITH | Vice President & Secretary | 520415 0.2761% | $0.90 | 0 | 4 | |
Peabody Robert | Sr. VP, COO, and CFO | 315777 0.1675% | $0.90 | 1 | 1 | +6.44% |
Mulroy Michael H. | 258555 0.1372% | $0.90 | 1 | 0 | <0.0001% | |
STERNBERG HAL | Vice President | 254270 0.1349% | $0.90 | 0 | 1 | |
WAITZ HAROLD D | Vice President | 184246 0.0978% | $0.90 | 0 | 2 | |
Cartt Stephen LaHue | director | 155125 0.0823% | $0.90 | 3 | 0 | +6.94% |
LICHTINGER PEDRO | director | 126250 0.067% | $0.90 | 2 | 0 | <0.0001% |
FARRELL STEPHEN C | director | 97450 0.0517% | $0.90 | 6 | 0 | <0.0001% |
MOHANTY ADITYA P. | Co-Chief Executive Officer | 89696 0.0476% | $0.90 | 1 | 0 | <0.0001% |
Russell Angus C. | director | 87500 0.0464% | $0.90 | 1 | 1 | <0.0001% |
Amin Dipti | 35000 0.0186% | $0.90 | 1 | 0 | <0.0001% | |
SCHLACHET DAVID | director | 32050 0.017% | $0.90 | 1 | 0 | +11.75% |
SEINBERG STEVEN A | Chief Financial Officer | 22500 0.0119% | $0.90 | 0 | 4 | |
ANDREWS DEBORAH J | director | 15578 0.0083% | $0.90 | 5 | 1 | <0.0001% |
BURNS ARNOLD I | director | 15000 0.008% | $0.90 | 1 | 0 | <0.0001% |
COHEN ABRAHAM E | director | 10000 0.0053% | $0.90 | 1 | 0 | <0.0001% |
Patton Stephana Eilene | General Counsel | 7500 0.004% | $0.90 | 1 | 0 | <0.0001% |
GARCIA PETER S | Chief Financial Officer | 7000 0.0037% | $0.90 | 2 | 0 | <0.0001% |
Roberts Brandi | CFO & SVP, Finance | 5000 0.0027% | $0.90 | 1 | 0 | <0.0001% |
Leavitt Chase C. | General Counsel/Secretary | 5000 0.0027% | $0.90 | 1 | 0 | <0.0001% |
TEW WILLIAM P PHD | Chief Commercial Officer | 3265 0.0017% | $0.90 | 0 | 5 | |
VON ESCHENBACH ANDREW C. | director | 3000 0.0016% | $0.90 | 1 | 0 | <0.0001% |
SKIBSTED RUSSELL | Chief Financial Officer | 2000 0.0011% | $0.90 | 1 | 0 | <0.0001% |
BERGER FRANKLIN M | director | 500 0.0003% | $0.90 | 1 | 0 | <0.0001% |
Hogge Gary S. | SVP,Clinical & Medical Affairs | 0 0% | $0.90 | 0 | 2 | |
GREGG VALETA A | director | 0 0% | $0.90 | 0 | 8 | |
Hernandez Alexandra | Sr Director Finance/Controller | 0 0% | $0.90 | 0 | 1 |
Broadwood Capital Inc | $61.67M | 22.07 | 41.67M | +19.27% | +$9.96M | 4.66 | |
BlackRock | $12.57M | 4.5 | 8.49M | -0.43% | -$54,912.43 | <0.0001 | |
The Vanguard Group | $12.39M | 4.43 | 8.37M | -0.13% | -$16,155.68 | <0.0001 | |
Logos Global Management Lp | $9.25M | 3.31 | 6.25M | New | +$9.25M | 0.99 | |
Defender Capital | $7.35M | 2.63 | 4.97M | -0.04% | -$2,960.00 | 2.5 | |
Geode Capital Management | $4.82M | 1.72 | 3.25M | +10.81% | +$469,587.56 | <0.0001 | |
Raffles Associates Lp | $4.75M | 1.7 | 3.21M | +50.59% | +$1.6M | 0.44 | |
State Street | $3.22M | 1.15 | 2.18M | +3.84% | +$119,287.99 | <0.0001 | |
Prescott General Partners Llc | $2.74M | 0.98 | 1.85M | 0% | +$0 | 0.15 | |
MAI Capital Management, LLC | $2.21M | 0.79 | 1.49M | +85.47% | +$1.02M | 0.02 | |
DAFNA Capital Management, LLC | $2.02M | 0.72 | 1.37M | New | +$2.02M | 0.47 | |
Bank of America | $1.94M | 0.69 | 1.31M | +5,397.34% | +$1.91M | <0.0001 | |
Northern Trust | $1.82M | 0.65 | 1.23M | +3.13% | +$55,295.76 | <0.0001 | |
Bridgeway Capital Management | $1.01M | 0.36 | 681,766 | -12.79% | -$148,000.05 | 0.02 | |
JPMorgan Chase | $1M | 0.36 | 675,704 | -7.06% | -$75,937.33 | <0.0001 | |
Renaissance Technologies | $785,000.00 | 0.28 | 530,600 | +253.73% | +$563,081.42 | <0.01 | |
Nuveen | $762,859.00 | 0.27 | 515,445 | 0% | +$0 | <0.0001 | |
Wellington Management Company | $691,966.00 | 0.25 | 467,545 | New | +$691,966.00 | <0.0001 | |
Morgan Stanley | $678,872.00 | 0.24 | 458,697 | -3.95% | -$27,926.14 | <0.0001 | |
Charles Schwab | $541,609.00 | 0.19 | 365,952 | +0.75% | +$4,050.76 | <0.0001 | |
BNY Mellon | $475,370.00 | 0.17 | 321,196 | -10.31% | -$54,671.19 | <0.0001 | |
Comerica | $370,437.00 | 0.13 | 250,295 | +84,745.77% | +$370,000.40 | <0.01 | |
Citadel Advisors LLC | $327,406.00 | 0.12 | 221,220 | -62.34% | -$541,989.98 | <0.0001 | |
Long Focus Capital Management Llc | $318,200.00 | 0.11 | 215,000 | 0% | +$0 | 0.04 | |
Connor Clark & Lunn Investment Management Ltd | $305,240.00 | 0.11 | 206,243 | +26.78% | +$64,468.88 | <0.01 | |
Squarepoint Ops LLC | $284,005.00 | 0.1 | 191,895 | +10.73% | +$27,523.60 | <0.01 | |
D. E. Shaw & Co. | $276,208.00 | 0.1 | 186,627 | New | +$276,208.00 | <0.0001 | |
T. Rowe Price | $239,000.00 | 0.09 | 161,314 | +77.47% | +$104,330.08 | <0.0001 | |
UBS | $207,306.00 | 0.07 | 140,072 | -3.08% | -$6,593.38 | <0.0001 | |
RhumbLine Advisers | $170,312.00 | 0.06 | 115,080 | +3.25% | +$5,363.32 | <0.0001 | |
Dcf Advisers Llc | $159,471.00 | 0.06 | 107,751 | +13.72% | +$19,239.94 | 0.1 | |
Jane Street Capital | $155,104.00 | 0.06 | 104,800 | -36.1% | -$87,632.28 | <0.0001 | |
Williams Jones Wealth Management Llc | $149,924.00 | 0.05 | 101,300 | 0% | +$0 | <0.01 | |
Barclays | $139,000.00 | 0.05 | 93,927 | -48.76% | -$132,248.82 | <0.0001 | |
Deutsche Bank | $110,850.00 | 0.04 | 74,899 | -1.96% | -$2,214.07 | <0.0001 | |
Jump Financial Llc | $107,817.00 | 0.04 | 72,849 | New | +$107,817.00 | <0.01 | |
MetLife Investment Management | $103,169.00 | 0.04 | 69,709 | +1.39% | +$1,413.40 | <0.01 | |
American International Group | $96,788.00 | 0.04 | 65,397 | -0.85% | -$831.76 | <0.0001 | |
Hightower Advisors | $95,000.00 | 0.03 | 63,971 | +18.31% | +$14,701.97 | <0.0001 | |
Wells Fargo | $89,357.00 | 0.03 | 60,376 | -0.95% | -$856.92 | <0.0001 | |
The Manufacturers Life Insurance Company | $86,407.00 | 0.03 | 58,383 | 0% | +$0 | <0.0001 | |
Invesco | $83,988.00 | 0.03 | 56,749 | -0.23% | -$192.40 | <0.0001 | |
Voya Investment Management LLC | $70,788.00 | 0.03 | 47,830 | -15.49% | -$12,972.13 | <0.0001 | |
CIBC World Markets | $68,000.00 | 0.02 | 46,050 | 0% | +$0 | <0.0001 | |
Beirne Wealth Consulting Services, LLC (BWC) | $66,600.00 | 0.02 | 45,000 | 0% | +$0 | 0.03 | |
LINSCO PRIVATE LEDGER CORP | $61,443.00 | 0.02 | 41,515 | -48.76% | -$58,459.28 | <0.0001 | |
Millennium Management LLC | $61,713.00 | 0.02 | 41,698 | -28.1% | -$24,123.98 | <0.0001 | |
UNITED BANK | $62,160.00 | 0.02 | 42,000 | +40.94% | +$18,056.00 | 0.01 | |
Dimensional Fund Advisors | $59,865.00 | 0.02 | 40,449 | 0% | +$0 | <0.0001 | |
Susquehanna International Group | $52,251.00 | 0.02 | 35,305 | -42.2% | -$38,145.23 | <0.0001 |